Psiquiatria Biologica最新文献_第8页

Síndrome anticolinérgico por biperideno, un complejo diagnóstico diferencial. A propósito de un caso 哌啶导致的抗胆碱能综合征，一种复杂的鉴别诊断。病例报告

Psiquiatria Biologica Pub Date : 2024-02-14 DOI: 10.1016/j.psiq.2024.100443

Ignacio Ramos Suárez, Antonio Martínez Cabezas

{"title":"Síndrome anticolinérgico por biperideno, un complejo diagnóstico diferencial. A propósito de un caso","authors":"Ignacio Ramos Suárez, Antonio Martínez Cabezas","doi":"10.1016/j.psiq.2024.100443","DOIUrl":"10.1016/j.psiq.2024.100443","url":null,"abstract":"<div><p>Various pharmacological groups can trigger a series of acute dysautonomias that have the following features in common: muscle rigidity, hyperthermia, and autonomic dysfunction.</p><p>All these dysautonomias are grouped within the so-called drug-induced hyperthermic syndromes. They are characterized by a hypermetabolic state secondary to taking medications and other agents that alter neurotransmitter levels. Three of these syndromes: neuroleptic malignant syndrome, serotonin syndrome and anticholinergic syndrome are of special relevance in the psychiatric field since they are associated with the taking of drugs widely used by their specialists.</p><p>All of them have high morbidity and mortality, which is why they require a multidisciplinary approach to guarantee adequate diagnosis and therapeutic management.</p><p>For all these reasons, we present the case of a 49-year-old woman admitted to the Mental Health Hospitalization Unit as a result of catatonic symptoms who, on the third day of admission, developed symptoms of dysautonomia and hyperthermia concomitant with taking Olanzapine, citalopram and biperiden reason for which a complex differential diagnosis is proposed between: NMS, SS vs. AS.</p></div>","PeriodicalId":39337,"journal":{"name":"Psiquiatria Biologica","volume":"31 2","pages":"Article 100443"},"PeriodicalIF":0.0,"publicationDate":"2024-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139875312","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Antidiabéticos orales y trastornos depresivos: ¿riesgo o protección? 口服抗糖尿病药与抑郁障碍：风险还是保护？

Psiquiatria Biologica Pub Date : 2024-01-01 DOI: 10.1016/j.psiq.2024.100441

Maria Raad-Sarabia , Maria Cardona-Blanco , Carmen Mendoza-Paternina , José Correa-Guerrero , Jorge Rico-Fontalvo , Rodrigo Daza-Arnedo , Zulay Mondol-Almeida , Jhonny Llinas-Rincon , Liseth Sierra-Torres , Juan Marrugo-Yunda

{"title":"Antidiabéticos orales y trastornos depresivos: ¿riesgo o protección?","authors":"Maria Raad-Sarabia , Maria Cardona-Blanco , Carmen Mendoza-Paternina , José Correa-Guerrero , Jorge Rico-Fontalvo , Rodrigo Daza-Arnedo , Zulay Mondol-Almeida , Jhonny Llinas-Rincon , Liseth Sierra-Torres , Juan Marrugo-Yunda","doi":"10.1016/j.psiq.2024.100441","DOIUrl":"10.1016/j.psiq.2024.100441","url":null,"abstract":"<div><h3>Introduction</h3><p>Diabetes mellitus and mood disorders are two entities that are intertwined with common pathophysiological mechanisms. Oral hypoglycemic agents are a fundamental pillar in obtaining adequate glucose control in diabetic individuals and, recently, the high prevalence of these two pathologies in the same patient have led clinical studies to focus on analyzing the effect of oral hypoglycemic agents in diabetics. patients with type 2 diabetes mellitus and depressive disorder.</p></div><div><h3>Objective</h3><p>To carry out a review of the available literature on hypoglycemic medication in the context of patients with diabetes mellitus and depressive disorder.</p></div><div><h3>Conclusions</h3><p>Although oral antidiabetics have been shown to have an antidepressant effect in certain experimental models, in clinical practice the evidence is scarce, but the lower risk of depression with certain antidiabetics is particularly noteworthy, leaving open the possibilities of future studies with the adequate nature that allows clarifying the effect of oral hypoglycemic agents in the population with diabetes mellitus and depressive disorder.</p></div>","PeriodicalId":39337,"journal":{"name":"Psiquiatria Biologica","volume":"31 1","pages":"Article 100441"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139458107","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Prevalencia de enfermedad psiquiátrica entre los suicidios consumados en la provincia de Badajoz en el periodo 2015-2017 2015-2017 年期间巴达霍斯省自杀者中的精神病患病率。

Psiquiatria Biologica Pub Date : 2024-01-01 DOI: 10.1016/j.psiq.2024.100446

Francisco J. Zamora-Rodríguez , María de la Luz Morales-Jiménez , Angel Benegas-Orrego

引用次数: 0

Coprolalia y copropraxia inducida por bupropión en un paciente autista y con trastorno obsesivo compulsivo 一名自闭症和强迫症患者因安非他明引起的秽语和秽语障碍

Psiquiatria Biologica Pub Date : 2024-01-01 DOI: 10.1016/j.psiq.2024.100444

Belén Sánchez Martín-Moreno, José Ángel Gila Azañedo

{"title":"Coprolalia y copropraxia inducida por bupropión en un paciente autista y con trastorno obsesivo compulsivo","authors":"Belén Sánchez Martín-Moreno, José Ángel Gila Azañedo","doi":"10.1016/j.psiq.2024.100444","DOIUrl":"https://doi.org/10.1016/j.psiq.2024.100444","url":null,"abstract":"<div><p>The case is presented of a 41-year-old male, admitted since age 26 to the Residential and Rehabilitation Unit with the diagnoses of autism spectrum disorder and obsessive-compulsive disorder, and under treatment with fluvoxamine, valproic, topiramate, risperidone and clonazepam. After a period of stability, a picture compatible with a major depressive episode appear, which is treated with bupropion, in order to affect the symptoms of apathy and psychomotor slowness. There is a rapid recovery in two weeks, but he begins to present copropraxia and coprolalia, which he had never presented before. Bupropion is withdrawn and coprolalia disappears in two weeks, but he maintained some of these behaviors, so cyproterone acetate is prescribed to control them, with improvement in one week. Three months after withdrawal of bupropion, he reaches euthymia and no longer presented any sexual behavioral alteration, coprolalia or copropraxia. The literature confirms other cases of appearance of tics in patients treated with antidepressants for a depressive picture and comorbidity with obsessive-compulsive disorder, but almost none by the use of bupropion or with coprolalia and copropraxia.</p></div>","PeriodicalId":39337,"journal":{"name":"Psiquiatria Biologica","volume":"31 1","pages":"Article 100444"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140031419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Programa de prevención del riesgo de suicidio «RENACE» 预防自杀风险计划 "RENACE"。

Psiquiatria Biologica Pub Date : 2024-01-01 DOI: 10.1016/j.psiq.2024.100449

Maria Aliño-Dies, Daniel Sánchez-Reolid, Marta Monferrer, Jorge J. Ricarte, María J. Montes, Antonio Fernández-Caballero, Patricia Fernández-Sotos, Luz María González Gualda

引用次数: 0

La depresión como factor de riesgo de la demencia: fisiopatología y modelos preclínicos de estudio 抑郁症是痴呆症的风险因素：病理生理学和临床前研究模型。

Psiquiatria Biologica Pub Date : 2024-01-01 DOI: 10.1016/j.psiq.2023.100439

Daniela Hernandez-Enseñat , Maylin Wong-Guerra , Jeney Ramírez-Sánchez , Luis Arturo Fonseca-Fonseca , Yanier Nuñez-Figueredo

引用次数: 0

Biomarcadores sanguíneos, de orina y conductas autolesivas e intentos de suicidio repetidos en los adolescentes 血液和尿液生物标志物与青少年的重复自残行为和自杀企图

Psiquiatria Biologica Pub Date : 2024-01-01 DOI: 10.1016/j.psiq.2024.100447

Ping Wang, Chao Li, Marina Martin-Moratinos, Marcos Bella-Fernández, Pablo del Sol, Leticia Mallol, María Elena Hernández-Álvarez, Encarnación Donoso-Navarro, María Gil-Ligero, Silvia Rosado-Garcia, Antonio Sanchez-Lopez, Hilario Blasco-Fontecilla

{"title":"Biomarcadores sanguíneos, de orina y conductas autolesivas e intentos de suicidio repetidos en los adolescentes","authors":"Ping Wang, Chao Li, Marina Martin-Moratinos, Marcos Bella-Fernández, Pablo del Sol, Leticia Mallol, María Elena Hernández-Álvarez, Encarnación Donoso-Navarro, María Gil-Ligero, Silvia Rosado-Garcia, Antonio Sanchez-Lopez, Hilario Blasco-Fontecilla","doi":"10.1016/j.psiq.2024.100447","DOIUrl":"https://doi.org/10.1016/j.psiq.2024.100447","url":null,"abstract":"<div><p>There is partial evidence that elevated levels of blood β-endorphin are associated with suicidal addiction in adults, but hardly any data on adolescents. Blood β-endorphin, with an important role in addiction management mechanisms, can induce euphoria and happiness, reward and reinforce suicidal behavior. To test whether high repeaters of suicide attempts (5 or more suicide attempts) and self-injurious behaviors (20 or more episodes of self-injury) have higher biomarker levels, a sample of 43 patients aged 12-17 years attending the Psychiatric Emergency Department at the Hospital Universitario Puerta de Hierro Majadahonda is recruited. Ten present 5 or more suicide attempts, 35 present 20 or more self-injurious episodes and 10 present both characteristics, and most of the adolescents meet addiction criteria for self-injury and suicide. The results suggest that all patients with addiction to suicide also had addiction to self-injury. Blood ACTH, cortisol and β-endorphin and urine cortisol levels were very elevated, but did not differentiate heavy repeaters from the rest of the adolescents.</p></div>","PeriodicalId":39337,"journal":{"name":"Psiquiatria Biologica","volume":"31 1","pages":"Article 100447"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140031429","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Aripiprazol: cuidado con la adicción patológica al juego 阿立哌唑：警惕病态赌博成瘾

Psiquiatria Biologica Pub Date : 2024-01-01 DOI: 10.1016/j.psiq.2023.100440

Pedro Moltó-Balado , Roxana Reverté-Gil

引用次数: 0

Intersección de síntomas en el trastorno del espectro autista y trastornos psicóticos: a propósito de un caso 自闭症谱系障碍和精神障碍的症状交叉：病例报告

Psiquiatria Biologica Pub Date : 2024-01-01 DOI: 10.1016/j.psiq.2024.100442

Sara Cabezas-Gutiérrez, Pablo Vázquez-Herrera, Batirtze Goitia-Aritxa

{"title":"Intersección de síntomas en el trastorno del espectro autista y trastornos psicóticos: a propósito de un caso","authors":"Sara Cabezas-Gutiérrez, Pablo Vázquez-Herrera, Batirtze Goitia-Aritxa","doi":"10.1016/j.psiq.2024.100442","DOIUrl":"https://doi.org/10.1016/j.psiq.2024.100442","url":null,"abstract":"<div><p>Autism spectrum disorder is a neurodevelopmental disorder with a current global prevalence of approximately 1%. It is common that the main symptoms of this disorder, such as deterioration in social interactions, restricted or atypical interests, and cognitive and verbal communication deficiencies, can be confused with symptoms of the psychotic sphere typical of schizophrenia. An adequate evaluation is necessary due that both entities can coexist with a variable prevalence of 12 to 50%. Moreover, both disorders can coexist with a variable prevalence of 12 to 50%. We present the clinical case of a woman who, at the age of 20, began follow-up in the mental health unit due to symptoms compatible with an obsessive-compulsive disorder along with a clinic characterized by apathy, anhedonia, abandonment of self-care and progressive functional deterioration. After several evaluation sessions, we diagnosed an autism spectrum disorder. We carry out a bibliographic review with which we conclude that the intersection of symptoms between autism and schizophrenia is common and clinical recommendations are provided to differentiate both clinical entities.</p></div>","PeriodicalId":39337,"journal":{"name":"Psiquiatria Biologica","volume":"31 1","pages":"Article 100442"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139908299","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Relación entre la capacidad adquirida y el riesgo suicida 获得能力与自杀风险之间的关系

Psiquiatria Biologica Pub Date : 2024-01-01 DOI: 10.1016/j.psiq.2024.100448

María Dolores Rus Guerrero, Zaira Morales Domínguez, Yolanda Torrico Linares, Esperanza Torrico Linares

引用次数: 0